You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API OLSALAZINE SODIUM

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing OLSALAZINE SODIUM

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Meda Pharmaceuticals Inc	DIPENTUM	olsalazine sodium	0037-6860	CARAMEL
Meda Pharmaceuticals Inc	DIPENTUM	olsalazine sodium	0037-6860	FERROSOFERRIC OXIDE
Meda Pharmaceuticals Inc	DIPENTUM	olsalazine sodium	0037-6860	GELATIN
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for OLSALAZINE SODIUM

Excipient focus: CARAMEL

OLSALAZINE SODIUM drug variants containing CARAMEL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals Inc	olsalazine sodium	0037-6860
Carilion Materials Management	olsalazine sodium	68151-0312
Carilion Materials Management	olsalazine sodium	68151-3120
>Company	>Ingredient	>NDC

OLSALAZINE SODIUM drug variants not containing CARAMEL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERROSOFERRIC OXIDE

OLSALAZINE SODIUM drug variants containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals Inc	olsalazine sodium	0037-6860
Carilion Materials Management	olsalazine sodium	68151-0312
Carilion Materials Management	olsalazine sodium	68151-3120
>Company	>Ingredient	>NDC

OLSALAZINE SODIUM drug variants not containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GELATIN

OLSALAZINE SODIUM drug variants containing GELATIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals Inc	olsalazine sodium	0037-6860
Carilion Materials Management	olsalazine sodium	68151-0312
Carilion Materials Management	olsalazine sodium	68151-3120
>Company	>Ingredient	>NDC

OLSALAZINE SODIUM drug variants not containing GELATIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

OLSALAZINE SODIUM drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals Inc	olsalazine sodium	0037-6860
Carilion Materials Management	olsalazine sodium	68151-0312
Carilion Materials Management	olsalazine sodium	68151-3120
>Company	>Ingredient	>NDC

OLSALAZINE SODIUM drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

OLSALAZINE SODIUM drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals Inc	olsalazine sodium	0037-6860
Carilion Materials Management	olsalazine sodium	68151-0312
Carilion Materials Management	olsalazine sodium	68151-3120
>Company	>Ingredient	>NDC

OLSALAZINE SODIUM drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.